ELV Deadline: ELV Investors with Losses in Excess of $100K Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit

Core Viewpoint - Rosen Law Firm is reminding purchasers of Elevance Health, Inc. common stock about a class action lawsuit with a lead plaintiff deadline of July 11, 2025, for those who bought shares between April 18, 2024, and October 16, 2024 [1][2]. Group 1: Class Action Details - Investors who purchased Elevance Health common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit claims that Elevance Health made false or misleading statements regarding the Medicaid redetermination process and its financial guidance, which led to investor damages when the truth was revealed [5]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors and has been recognized for its performance in securities class action settlements [4].